Specific Lp(a) Apheresis for Regression of Coronary and Carotid Atherosclerosis

NCT ID: NCT02133807 Phase: PHASE3 Status: COMPLETED Enrollment: 32 Completion: 2012-06

Conditions

Atherosclerosis, Coronary Disease, Carotid Artery Diseases

Interventions

Specific Lp(a) apheresis

Summary

To evaluate whether specific lipoprotein(a) apheresis on the top of optimal medical therapy could affect atherosclerotic disease burden in coronary and carotid arteries of coronary heart disease patients with elevated Lp(a) levels.

Primary Outcome

Change in Percent Diameter Stenosis

Source

ClinicalTrials.gov